Recent scientific data revealed that the nonadherence to hepatitis B medicines increases the risk for hepatocellular carcinoma and cirrhosis followed by mortality.
Current HIV drugs usually act on enzymes needed by the virus throughout its survival. But no drug targets the outermost layer of the virus named the capsid, which protects the genetic material delivered into the host.
A New York-based company named Siga Technologies has won FDA approval for its oral formulation of tecovirimat, used to treat smallpox, in case there occurs an outbreak.
A new technique allows scientists to measure how efficiently cancer drugs reach their targets inside the body in real time, differentiating cells that interact with the drug from those which do not.
Royal Free London NHS Foundation Trust and Teesside University researchers helped organize a ‘hackathon’ on 4 and 5 July 2018 at Brunel University in London with an aim to develop virtual reality (VR) tools for patients.
Researchers from South Ural State University (SUSU) found that man has been suffering from Hepatitis B since the Bronze Age with the help of viral traces in the genomes of ancient people. To understand how some of the ancient diseases spread and to find out how they might behave in the future, an international collaboration between researchers had been analyzing DNA of the relics of ancient people found in areas from Mongolia to Europe for several years.
In a joint venture, German biopharmaceutical firm BioNTech and Genevant Sciences, a genetic disorder therapeutics maker plan to develop mRNA therapy programmes targeting rare diseases with severely deficient medical attention.
Sanction of a single 300mg dose of GlaxoSmithKline’s tafenoquine in patients 16 years and above for the "radical cure" of malaria was advocated by an FDA advisory committee on finding significant evidence for its efficacy and safety.
The condition is termed as toxic hepatitis, where the exposure to toxins leads to liver inflammation. These toxins can be the result of an overdose of certain medicines.
Dr. Lionel Piroth and Dr. Marine Jacquier from the Centre Hospitalier Universitaire in Dijon reported in the New England Journal of Medicine, “A 35-year-old French woman presented to the emergency department with weakness, a feeling of electric shocks in both legs, and repeated falls; She reported that the symptoms had been progressing, and she noted that she had had difficulty riding her horse for the preceding three months.”
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.